The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized open label exploratory controlled trial of CLT-008 myeloid progenitor cells (MPC) to decrease infections during induction for AML.
 
Camille N. Abboud
Stock and Other Ownership Interests - Abbott Laboratories (I); Abbvie (I); Gilead Sciences (I); Merck (I)
Honoraria - Agios; Novartis; Pfizer
Consulting or Advisory Role - Gerson Lehrman Group
Speakers' Bureau - Jazz Pharmaceuticals
Research Funding - Cellerant (Inst); Merck (Inst); Novartis (Inst); Novartis (Inst); Pfizer (Inst)
 
Luke Paul Akard
Speakers' Bureau - Bristol-Myers Squibb; Celgene; Gilead Sciences; Novartis; Takeda; Teva
 
Charalambos Andreadis
Employment - Genentech (I)
Stock and Other Ownership Interests - Roche/Genentech (I)
Consulting or Advisory Role - Astellas Pharma; Bayer; Genentech/Roche; Gilead Sciences; Kite, a Gilead company; Pharmacyclics; Seagen; Spectrum Pharmaceuticals
Research Funding - Amgen; Cellerant; GlaxoSmithKline; Karyopharm Therapeutics; Novartis
 
Pinkal M. Desai
Employment - MB Pharma (I)
Honoraria - Agios; Argenx
Consulting or Advisory Role - Agios; Argenx
 
James M. Foran
Honoraria - Incyte
Consulting or Advisory Role - Boehringer Ingelheim; Pharmacyclics; Sunesis Pharmaceuticals
Research Funding - Astellas Pharma (Inst); Celgene (Inst); Cellerant (Inst); Millennium (Inst); Seagen (Inst); TetraLogic Pharmaceuticals (Inst)
 
Olga Frankfurt
Consulting or Advisory Role - Agios
Speakers' Bureau - Celgene; Jazz Pharmaceuticals
 
Saar Gill
Honoraria - Alexion Pharmaceuticals
Research Funding - Novartis (Inst)
Patents, Royalties, Other Intellectual Property - Patents for chimeric antigen receptor T cells for acute myeloid leukemia
 
Jack W. Hsu
Consulting or Advisory Role - Astellas Pharma; Kite, a Gilead company; Seagen
Research Funding - Astellas Pharma (Inst); Cellerant (Inst); Daiichi Sankyo (Inst)
 
John Lister
Consulting or Advisory Role - Oncology Analytics
 
John M. Pagel
Consulting or Advisory Role - Gilead Sciences; Pharmacyclics
 
Gary J. Schiller
Research Funding - Cellerant (Inst)
 
Melham M. Solh
Consulting or Advisory Role - Amgen
Speakers' Bureau - Amgen; Celgene
 
Celalettin Ustun
Honoraria - Novartis
Speakers' Bureau - Novartis
 
Matthew Joseph Wieduwilt
Stock and Other Ownership Interests - Reata Pharmaceuticals
Research Funding - ADC Therapeutics (Inst); Amgen (Inst); Cantex (Inst); Jazz Pharmaceuticals (Inst); Merck (Inst); Shire (Inst); Sigma-Tau (Inst)
 
Brown Janice
Consulting or Advisory Role - Astellas Pharma; Cellerant; Merck
Research Funding - Astellas Medivation; Merck
Patents, Royalties, Other Intellectual Property - Stanford University
 
Alicia Wong
Employment - Cellerant
Travel, Accommodations, Expenses - Cellerant
 
Lois Kellerman
Employment - Cellerant
Travel, Accommodations, Expenses - Cellerant
 
Rodney Van Syoc
Employment - Cellerant
Stock and Other Ownership Interests - Anacor (I); Dermira (I)
 
Rick Mamelok
Leadership - Apricity Therapeutics
Stock and Other Ownership Interests - Amgen; Johnson & Johnson; Merck; Pfizer; Roche
Consulting or Advisory Role - Acadia Pharmaceuticals; Allergan; Cellerant Therapeutics; Dermira; Eleven Biotherapeutics; Exelixis; Jazz Pharmaceuticals
 
Farhad Ravandi
Honoraria - Amgen; Pfizer; Seagen; Sunesis Pharmaceuticals
Consulting or Advisory Role - Amgen; Seagen; Sunesis Pharmaceuticals
Research Funding - Amgen; Bristol-Myers Squibb; Merck; Seagen; Sunesis Pharmaceuticals